207 related articles for article (PubMed ID: 26629947)
1. TIP30: A Novel Tumor-Suppressor Gene.
Yu X; Li Z; Wu WK
Oncol Res; 2014; 22(5-6):339-48. PubMed ID: 26629947
[TBL] [Abstract][Full Text] [Related]
2. TIP30 deficiency increases susceptibility to tumorigenesis.
Ito M; Jiang C; Krumm K; Zhang X; Pecha J; Zhao J; Guo Y; Roeder RG; Xiao H
Cancer Res; 2003 Dec; 63(24):8763-7. PubMed ID: 14695192
[TBL] [Abstract][Full Text] [Related]
3. [Effects of tumor suppressing gene TIP30/CC3 on the growth of tumor cells].
Zhang X; Ouyang XN; Li XD; Zhao J; Guo YJ
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):38-41. PubMed ID: 15670490
[TBL] [Abstract][Full Text] [Related]
4. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CC3/TIP30 is associated with HER-2/neu status in breast cancer.
Zhang DH; Wong LL; Tai LK; Koay ES; Hewitt RE
J Cancer Res Clin Oncol; 2005 Sep; 131(9):603-8. PubMed ID: 15931508
[TBL] [Abstract][Full Text] [Related]
6. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU.
Zhao J; Zhang X; Shi M; Xu H; Jin J; Ni H; Yang S; Dai J; Wu M; Guo Y
Hepatology; 2006 Jul; 44(1):205-15. PubMed ID: 16799960
[TBL] [Abstract][Full Text] [Related]
7. Expression of TIP30 tumor suppressor gene is down-regulated in human colorectal carcinoma.
Chen X; Cao X; Dong W; Luo S; Suo Z; Jin Y
Dig Dis Sci; 2010 Aug; 55(8):2219-26. PubMed ID: 19798571
[TBL] [Abstract][Full Text] [Related]
8. TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression.
Zhao J; Ni H; Ma Y; Dong L; Dai J; Zhao F; Yan X; Lu B; Xu H; Guo Y
Hum Pathol; 2007 Feb; 38(2):293-8. PubMed ID: 17097132
[TBL] [Abstract][Full Text] [Related]
9. Tat-Interacting Protein 30 (TIP30) Expression Serves as a New Biomarker for Tumor Prognosis: A Systematic Review and Meta-Analysis.
Xu T; Jin Z; Yuan Y; Zheng H; Li C; Hou W; Guo Q; Hua B
PLoS One; 2016; 11(12):e0168408. PubMed ID: 28036326
[TBL] [Abstract][Full Text] [Related]
10. TIP30 is associated with progression and metastasis of prostate cancer.
Zhang H; Zhang Y; Duan HO; Kirley SD; Lin SX; McDougal WS; Xiao H; Wu CL
Int J Cancer; 2008 Aug; 123(4):810-6. PubMed ID: 18528861
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.
Bu F; Liu X; Li J; Chen S; Tong X; Ma C; Mao H; Pan F; Li X; Chen B; Xu L; Li E; Kou G; Han J; Guo S; Zhao J; Guo Y
Oncotarget; 2015 Feb; 6(4):2120-33. PubMed ID: 25544767
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30.
Guo Z; Cao M; You A; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Sun H; Zhang T
Cancer Sci; 2016 Apr; 107(4):507-13. PubMed ID: 26752068
[TBL] [Abstract][Full Text] [Related]
13. Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection.
Zhang X; Lv L; Ouyang X; Zhang S; Fang J; Cai L; Li D
Cancer Med; 2016 Sep; 5(9):2180-9. PubMed ID: 27418384
[TBL] [Abstract][Full Text] [Related]
14. Reduction of TIP30 in esophageal squamous cell carcinoma cells involves promoter methylation and microRNA-10b.
Dong W; Shen R; Cheng S
Biochem Biophys Res Commun; 2014 Oct; 453(4):772-7. PubMed ID: 25312779
[TBL] [Abstract][Full Text] [Related]
15. Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis.
Li X; Zhang Y; Cao S; Chen X; Lu Y; Jin H; Sun S; Chen B; Liu J; Ding J; Wu K; Fan D
Int J Cancer; 2009 Feb; 124(3):713-21. PubMed ID: 18972434
[TBL] [Abstract][Full Text] [Related]
16. TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes.
Xiao H; Palhan V; Yang Y; Roeder RG
EMBO J; 2000 Mar; 19(5):956-63. PubMed ID: 10698937
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland.
Pecha J; Ankrapp D; Jiang C; Tang W; Hoshino I; Bruck K; Wagner KU; Xiao H
Oncogene; 2007 Nov; 26(53):7423-31. PubMed ID: 17533366
[TBL] [Abstract][Full Text] [Related]
18. MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S
Mol Med Rep; 2016 Nov; 14(5):4581-4592. PubMed ID: 27748889
[TBL] [Abstract][Full Text] [Related]
19. TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in mice.
Li A; Zhang C; Gao S; Chen F; Yang C; Luo R; Xiao H
Oncogene; 2013 May; 32(18):2273-81, 2281e.1-12. PubMed ID: 22733137
[TBL] [Abstract][Full Text] [Related]
20. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
